HealthInvest Partners’s Maravai LifeSciences MRVI Stock Holding History

HealthInvest Partners’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$6.8K	Buy	+475	New	+$7.48K	0.01%	43

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

HealthInvest Partners's MRVI Position: Q4 2022 in Review

HealthInvest Partners opened a new position in Maravai LifeSciences (MRVI) in Q4 2022: 475 shares worth $6.8K. The stake represents 0.01% of the portfolio and ranks #43 among its holdings.

212 funds tracked by Wall St. Rank hold MRVI as of Q4 2022.

HealthInvest Partners held 475 shares of Maravai LifeSciences worth $6.8K as of Q4 2022.
Maravai LifeSciences was a new HealthInvest Partners position in Q4 2022.
Maravai LifeSciences made up 0.01% of HealthInvest Partners's portfolio in Q4 2022, its #43 holding.
212 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q4 2022.

Based on HealthInvest Partners's 13F filing for Q4 2022, filed 14 Feb 2023.